MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.urology.2007.07.017

Медицинская библиотека · Urology · 2007

The safety and efficacy of different doses of bacillus Calmette Guérin in superficial bladder transitional cell carcinoma.

Agrawal Madhu S, Agrawal Moneet, Bansal Sumit, Agarwal Mayank, Lavania Prashant, Goyal Jitendra

СтатьяРандомизированное исследованиеПеревод в очереди

Аннотация

OBJECTIVES

To conduct a trial using three different doses of bacillus Calmette-Guérin (BCG) to determine whether lowering the dose of BCG could reduce toxicity without compromising its efficacy in the treatment of superficial bladder cancer.

METHODS

From July 2002 to June 2005, 152 patients with superficial bladder cancer entered the trial. The patients were randomized to receive three different doses of BCG: 40, 80, and 120 mg. There were no significant differences in clinical and pathologic characteristics among the three groups. Twenty-four patients could not be followed to the end of the study because of poor compliance. At completion of the study, 40 patients could be evaluated in group A (40 mg), 48 in group B (80 mg), and 40 in group C (120 mg).

RESULTS

After treatment patients were evaluated for a mean follow-up period of 36 months (range 18 to 52 months). No significant difference in recurrence rate (20% versus 25% versus 20% respectively; P >0.05) was observed among the groups, and no progression of the disease was seen. Significant differences were observed among groups A, B, and C in local toxicity (30% versus 41.7% versus 70%, respectively; P <0.01). Systemic toxicity was more common in group C compared with groups B and A (P <0.01).

CONCLUSIONS

Reduction in the dose of intravesical BCG can reduce the toxicity associated with the treatment of superficial bladder cancer without affecting the efficacy of therapy.

Для цитирования: Agrawal Madhu S, Agrawal Moneet, Bansal Sumit, Agarwal Mayank, Lavania Prashant, Goyal Jitendra. The safety and efficacy of different doses of bacillus Calmette Guérin in superficial bladder transitional cell carcinoma.. Urology. 2007. DOI: 10.1016/j.urology.2007.07.017.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.